Year 2015 - Present
SCT Presentation
 
  • Kline, Peyton
  • Screen Failure to Screen Success.
  • Society of Clinical Research Associates (SOCRA) Annual Conference. Oral presentation.
  • Kline, P., Staugaitis, A., Kassir, A., Butler, S., Staloch, J., and Stevenson, V.
  • How different communication pathways impact the success of a clinical trial, a multifaceted perspective.
  • Society of Clinical Trials (SCT). Oral presentation.
  • Bayesian Enrollment Modeling for Several Emergency Medicine Clinical Trials
  • (Poster). Society for Clinical Trials. Baltimore, Maryland. May 2023.
  • Bayesian Predictive Probabilities After Multiple Imputation
  • (Poster). Society for Clinical Trials. Baltimore, Maryland. May 2023.
  • Clustering multivariate longitudinal data using multidimensional tensor product smoothing splines and composite variables.
  • ENAR 2023 Spring meeting, March 2023.
  • Autoimmune hepatitis: A collaboration with Northwestern Medicine.
  • Department of Public Health Sciences Brown Bag Seminar, Medical University of South Carolina, November 2022.
  • Clustering multivariate longitudinal data using multidimensional tensor product smoothing splines and composite variables.
  • Student Research Day, Medical University of South Carolina, November 2022.
  • Interpreting a Bayesian Futility Clinical Trial.
  • (Poster). Society for Clinical Trials. May 2022. San Diego, California.
  • Developing Adaptive Trial Designs: A Collaborative Process Balancing Statistical Efficiency with Clinical Importance: KESET Trial Design.
  • Society for Clinical Trials 2022. May 2022. San Diego, California.
  • Bayesian Hierarchical Profile Regression for Binary Data.
  • St. Jude Children’s Hospital Future Fellows Research Conference, August 2021. St. Jude Children’s Hospital, Memphis, TN.
  • Accelerating Evidence Generation through Quality by Design.
  • SCT Workshop Moderator. May 2021.
  • Innovations in Academic Data Analysis and Coordinating Centers- Improving Quality through Collaboration.
  • SCT - Society for Clinical Trials. May 2021. Invited speaker-panel.
  • Improving Quality and Controlling Costs in Clinical Trials using Responsive Survey Design.
  • SCT Webinar Moderator. March 2021.
  • Using Longitudinal Data to Build a Better Prediction Model for Transplant-Free Survival After Acute Liver Failure.
  • Acute Liver Failure Study Group (ALFSG) Steering Committee Meeting, Virtual, January 2021.
  • Classification of Physiologic Swallowing Impairment Severity: A Latent Class Analysis of Modified Barium Swallow Impairment Profile Scores.
  • Dysphagia Research Society 2020, Online
  • How to Account for Transplant When Examining Survival in Acute Liver Failure Research.
  • Student Research Day, Medical University of South Carolina, November 2019.
  • How to Account for Transplant When Examining Survival in Acute Liver Failure Research.
  • Department of Public Health Sciences Brown Bag Seminar, Medical University of South Carolina, October 2019.
  • Latent Pattern Models with Application to Dysphagia Severity.
  • Department of Public Health Sciences, Medical University of South Carolina Department Brown Bag. 2019. Charleston, South Carolina.
  • Invited speaker presenting: Implementation of an Innovative Lab Kit & Bio-sample Specimen Tracking within a Clinical Trial Management System.
  • SCT - Society for Clinical Trials. New Orleans, LA. May 2019.
  • Randomization Simulation for the Sleep SMART Clinical Trial.
  • Data Coordination Unit Brown Bag Seminar, Medical University of South Carolina, April 2019.
  • New Educational Initiative to Enhance TCD Implementation: Results from the DISPLACE Study.
  • SCDAA - Sickle Cell Disease Association of America. Baltimore, MD. 2019.
  • MUSC DISPLACE Phase 1 Trial.
  • ASH – American Society of Hematology. San Diego, CA. December 2018.
  • A Logic Ensemble Model for Identification of Interactions Associated with Continuous Disease Phenotypes.
  • (Poster presentation) Student Research Day, Medical University of South Carolina, November 2018.
  • A Logic Ensemble Model for Identification of Interactions Associated with Continuous Disease Phenotypes.
  • South Carolina Chapter of the American Statistical Association (SC-ASA) South Carolina Statistics Consortium, Clemson, SC, October 2018.
  • Ponce MC, Cassarly C, Simpson AN, Simpson KN, Flume PA.
  • Analysis of Treatment for Pulmonary Mycobacterium Avium Complex Infection using a Claims Database.
  • October 2018 at the CHEST Annual Meeting. San Antonio, TX. Oral presentation.
  • Estimating severity from video-fluoroscopic metrics: What’s mild, moderate or severe?
  • Charleston Swallowing Conference, July 2018. Northwestern University, Evanston, IL.
  • Dubno JR, Cassarly C, Matthews LJ, Simpson AN.
  • Changes in Self-Reported Hearing Handicap Across the Lifespan.
  • June 2018. Hearing Across the Lifespan Conference. Lake Como, Italy. Oral presentation.
  • Jeans, K., Linke, M., Sparks, D., Spilker, J., Dillon, C., … & Broderick, J.
  • Integration of Department of Veterans Affairs Medical Facilities into the Stroke Trial Network.
  • 2017 Advancing Ethical Research Conference (2017, November). San Antonio, TX.
  • Palesch YY, Ramakrishnan V, Foster L, Martin RL, Cassarly C, Barsan WG, Moy CS, Qureshi AI.
  • Outcome analysis for Antihypertensive Treatment for Acute Cerebral Hemorrhage (ATACH) II Trial using repeated systolic blood pressure measures. (Oral)
  • European Stroke Organization Conference, Prague, May 2017.
  • Farrant M, Johnston C, Easton D, Kim AS, Barsan W, Elm J, Lindblad A, Palesch Y.
  • Platelet Oriented Inhibition in New TIA and Minor Ischemic Stroke. (Poster)
  • European Stroke Organization Conference, Prague, May 2017.
  • Dillon, C., Zhao, W., Henry, A., Huang, D., & Kim, J.
  • Implementation of Clinical Trial Management Functionality for Remote Monitoring of Informed Consents
  • 38th Annual Society for Clinical Trial Meeting, May 2017, Liverpool, UK
  • Zhao, W., Pauls, K., Dillon, C., Kim, J.,Arnaud, C.,Ellerbe, C.,Elm, J.
  • Architectural Design of Automated Study Drug Distribution Coordination Module Integrated in Web-Based Clinical Trial Management System.
  • 38th Annual Society for Clinical Trial Meeting, May 2017, Liverpool, UK
  • Morotti A, Boulouis G, Romero J, Brouwers B, Jessel M, Vashkevich A, Schwab K, Afzal MR, Cassarly C, Greenberg S, Martin RH, Qureshi A, Rosand J, Goldstein J.
  • Targeting Expansion in Intracerebral Hemorrhage: Intensive Blood Pressure Reduction and Non-Contrast CT Markers.
  • May 2017. European Stroke Organisation Conference. Prague, Czech Republic. Oral presentation.
  • Shoamanesh A, Morotti A, Romero JM, Oliveira Filho J, Ayres A, Afzal MR, Cassarly C, Martin RH, Qureshi AI, Greenberg SM, Rosand J, Goldstein JN.
  • Cerebral Microbleeds, Hematoma Expansion and Outcomes: Observations from the ATACH-II Trial.
  • May 2017. World Intracranial Hemorrhage Conference. Baltimore, MD. Oral presentation.
  • Kurt Denninghoff, Tomas Nuño, Qi Pauls, Sharon D. Yeatts, Robert Silbergleit, Yuko Y. Palesch, Lisa H. Merck, Geoff Manley, and David W. Wright.
  • Prehospital Intubation is associated with favorable outcomes in ProTECT III.
  • SAEM
  • Dillon, C. & Zhao, W.
  • Enhancing Clinical Trial Quality and Efficiency by Integrating Trial Operation Information and Case Report Form Data.
  • 6th Annual Clinical Data Integration & Management meeting (2017, March). Princeton, NJ
  • Morotti A, Brouwers HB, Romero JM, Jessel MJ, Vashkevich A, Schwab K, Afzal MR, Cassarly C, Greenberg SM, Martin RH, Qureshi AI, Rosand J, Goldstein JN, On Behalf of ATACH-II and NETT Investigators*. (*Palesch Y acknowledged as a member of the ATACH II Investigators).
  • Intensive Blood Pressure Reduction and Spot Sign in Intracerebral Hemorrhage. (Oral)
  • International Stroke Conference, Houston, February 2017.
  • Qureshi AI, Foster LD, Martin RL, Palesch YY, for ATACH II Investigators.
  • Analysis of Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) II Trial by As Treated Groups. (Oral)
  • International Stroke Conference, February 2017.
  • Qureshi AI, Foster LD, Martin RL, Palesch YY, for ATACH II Investigators.
  • Effect of Intensive Systolic Blood Pressure Lowering on Hematoma Expansion in Patients with Intracerebral Hemorrhage: Analysis of Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) II Trial. (Oral)
  • International Stroke Conference Nursing Symposium, February 2017.
  • Broderick JP, Palesch Y, Zhao W, Janis S, Moy C.
  • NIH StrokeNet Evolving Trial Proposal Process. (Poster)
  • International Stroke Conference, Houston, February 2017.
  • Morotti A, Brouwers B, Romero JM, Jessel MJ, Vashkevich A, Schwab K, Cassarly C, Greenberg SM, Martin RH, Qureshi AI, Rosand J, Goldstein JN.
  • Does the CT Angiography Spot Sign Identify Intracerebral Hemorrhage Patients More Likely to Benefit From Intensive Blood Pressure Reduction?
  • February 2017. International Stroke Conference. Houston, TX. Oral presentation.
  • Peter Cotton, Qi Pauls, Valerie Durkalski, Jamila Keith, April Wood.
  • The EPISOD study; outcomes at 5 years.
  • DDW
  • Dillon, C. & Zhao, W.
  • Quality Data Management in Clinical Trials.
  • 4th Annual Innovations in Clinical Data Management meeting (2016, October). Arlington, VA.
  • Khattak F
  • Improving the Quality of Data Capture in Accident & Emergency Departments to Tackle Violence in the Community
  • The Mayor’s Office of London for Policing and Crime: ISTV Conference, October 2016, London, UK
  • Dillon, C., Huff, T., Meurer, W, & Zhao, W.
  • Challenges and Solutions for the Data Management of Emergency Clinical Trials.
  • The Society for Clinical Data Management, Annual meeting (2016, September). San Diego, CA.
  • Dillon, C., Elm, J., Harney, D., & Silbergleit, R.
  • Challenges and Solutions to the Coordination and Conduct of an Emergency Treatment Trial.
  • Presentation at the annual meeting of the Society for Clinical Trials (2016, May), Montreal, Canada.
  • Dillon, C., Link, M., & Silbergleit, R.
  • Central IRBs: Implementation, Effectiveness, and Optimization.
  • Presentation at the annual meeting of the Society for Clinical Trials (2016, May), Montreal, Canada.
  • Qureshi AI, Palesch YY, Barsan WG, Hanley DF, Hsu CY, Martin RL, Moy CS, Silbergleit R, Steiner T, Suarez JI, Toyoda K, Wang Y, Yamamoto H, Yoon BW, for the ATACH II Investigators.
  • Antihypertensive Treatment for Cerebral Hemorrhage (ATACH) II Trial. (Oral)
  • Large Clinical Trials Plenary Session at the European Stroke Organization Conference, Barcelona, Spain, May 2016.
  • Palesch YY, Qureshi AI, Barsan WG, Hanley DF, Hsu CY, Martin RL, Moy CS, Silbergleit R, Steiner T, Suarez JI, Toyoda K, Wang Y, Yamamoto H, Yoon BW, for the ATACH II Investigators.
  • Antihypertensive Treatment for Cerebral Hemorrhage (ATACH) II Trial: Subgroup analysis of data from Asian and non-Asian sites. (Oral)
  • Large Clinical Trials Plenary Session at the European Stroke Organization Conference, Barcelona, Spain, May 2016.
  • Mu Y, Pavlov A, Yeatts SD, Saver JL, Khatri P.
  • Analyzing the modified Rankin Scale in Acute Stroke Clinical Trials.
  • Presented at the European Stroke Organization Conference, Barcelona. May 2016. Poster presentation.
  • Mu Y, Pavlov A, Yeatts SD, Khatri P.
  • Designing Stroke Clinical Trials with a Binary Endpoint: Determining the Appropriate Sample Size Inflation Factor for Non-adherence.
  • Presented at the European Stroke Organization Conference, Barcelona. May 2016. Poster presentation.
  • Peter Cotton, Valerie Durkalski, Qi Pauls, April Wood for the EPISOD study team.
  • The EPISOD study; outcomes at 3 years.
  • DDW
  • Fan L, Yeatts SD, Wolf BJ, McClure LA, Selim M, Palesch YY.
  • The Estimation of Misclassification via Continuous-time Hidden Markov Model.
  • Presented at the Eastern North American Region of the International Biometrics Society Spring Meeting, Austin TX. March 2016. Oral presentation.
  • Ohio Safety Conference & Medical Health Symposium.
  • Columbus, OH. March 10-11 2016.
  • Liebeskind DS, Hill MD, Jovin TG, Menon BK, Nogueira RG, Zaidat OO, Scalzo F, Demchuk AM, Carrozzella J, von Kummer R, Khatri P, Goyal M, Yan B, Foster LD, Yeatts SD, Palesch YY, Broderick JP, Tomsick TA, Yoo AJ, for the IMS III Investigators.
  • Grade 2 or Partial Collaterals in IMS III: Half Full or Half Empty? (Poster)
  • International Stroke Conference, Los Angeles, CA, February 2016.
  • Lansberg M, Bhat N, Broderick JP, Palesch YY, Lavori,PW, Lai TL, Yeatts SD, Albers GW.
  • A Novel Adaptive Trial Design Increases the Power of Endovascular Stroke Studies. (Poster)
  • International Stroke Conference, Los Angeles, CA, February 2016.
  • Albers GA, Lansberg M, Kemp S, Christensen S, Tsai J, Mlynash M, Kim S, Zaharchuck G, Yeatts S, Wintermark M, Bammer R, Palesch Y, Lavori P, Broderick JP, Marks M, on behalf of the DEFUSE 3 Investigators.
  • DEFUSE 3 (Poster)
  • International Stroke Conference, Los Angeles, CA, February 2016.
  • Broderick JP, Palesch YY, Zhao W, Moy CS, Janis S.
  • NIH StrokeNet Trial Proposal Process. (Poster)
  • International Stroke Conference, Los Angeles, CA, February 2016.
  • Farrant M, Johnston C, Easton D, Kim AS, Barsan W, Elm J, Lindblad A, Palesch Y.
  • Platelet Oriented Inhibition in New TIA and Minor Ischemic Stroke. (Poster)
  • International Stroke Conference, Los Angeles, Feb 2016.
  • Simpson KN, Broderick JP, Simpson AN, Foster L, Hill MD, Jauch E, Palesch YY, for the IMS III Investigators.
  • Residual Stroke Morbidity and Post-acute Care Cost: the IMS III Economic Data Cohort. (Oral)
  • International Stroke Conference, Los Angeles, CA, February 2016.
  • Alejandro L. Suarez, MD, Peter B. Cotton, MD FRCP FRCS, Qi Pauls, MS, Valerie Durkalski-Mauldin, PhD, Gregory A. Coté, MD, MS.
  • Sphincter of Oddi dysfunction: A survey of current practice in USA.
  • DDW
  • ETF-Based Models for Liquidity Risk.
  • Joint Mathematics Meeting. January 2016. Seattle, Washington.
  • Cassarly C, Martin R, Chimowitz M, Pena E, Ramakrishnan V, Palesch Y.
  • Assessing Type I Error and Sample Size Requirements of Multistate Markov Models for Panel Data-A Simulation Study.
  • November 2015. MUSC Perry Halushka Research Day. Charleston, SC. Oral presentation.
  • Pauls K, Kim J, Zhao W.
  • Automated Coordination of Regulatory Document Collection in Large Clinical Trial Networks
  • Society for Clinical Trials 36th Annual Meeting, May 2015, Arlington, VA
  • Linke M, … Dillon C., et al.
  • Cooperative Review Process of the NIH StrokeNet Central Institutional Review Board
  • AAHRPP Annual Conference, May 2015, Chicago, IL
  • Dillon, C., Zhao, W., Simons, J., & Palesch, Y.
  • Building a Strong Data Management Center for the National Institutes of Health’s Stroke Trials Network.
  • Presentation at the annual meeting of the Society for Clinical Trials (2015, May), Crystal City, MD.
  • Kim J, Zhao W, Yeatts SD
  • Implementation of Advanced Randomization Algorithm with Integrated Study Drug Tracking
  • Society for Clinical Trials 36th Annual Meeting, May 2015, Arlington, VA, Oral presentation
  • Foster LD, Durkalski V.
  • Stopping Early in a Non-Inferiority Trial when the Primary Efficacy Outcome is Also the Primary Safety Outcome.
  • . Society for Clinical Trials Annual Meeting. Arlington, VA, 2015 May 19. (oral presentation)
  • Belagaje S, Foster L, Kissela B, Broderick J.
  • The Role of Discharge Disposition in the Interventional Management of Stroke (IMSIII) Trial.
  • American Academy of Neuroradiology Annual Meeting, Washington, DC, 2015 Apr. (poster)
  • Fan L, Yeatts SD, Wolf BJ, McClure LA, Selim M, Palesch YY.
  • The Impact of Covariate Misclassification using Generalized Linear Regression under Covariate-Adaptive Randomization.
  • Presented at the Eastern North American Region of the International Biometrics Society Spring Meeting, Miami FL. March 2015.
  • Tomsick T, Foster LD, Yeatts SD, Hill MD, Carrozzella J, Liebskind DS, Khatri P, Goyal M, Puetz V, Dzialowski I, Morales H, Demchuck AM, Palesch YY, Broderick JP.
  • Intraarterial (IA) Iodinated Radiographic Contrast Media (IRCM) Effect in the Interventional Management of Stroke (IMS) III Trial.
  • International Stroke Conference, Nashville, TN, 2015 Feb. (poster)
  • Vagal A, Foster L, Menon B, Livorine A, Shi J, Qazi E, Demchuck A, Yeatts S, Hill M, Tomsick T, Goyal M.
  • Multimodal CT Imaging: Time to Treatment and Outcomes in the Interventional Management of Stroke (IMS) III Trial.
  • International Stroke Conference, Nashville, TN, 2015 Feb. (oral presentation)
go to DPHS

go to MUSC